Suppr超能文献

用于靶向乳腺癌细胞的新型可生物降解纳米颗粒的比较评估。

Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.

作者信息

Mattu C, Pabari R M, Boffito M, Sartori S, Ciardelli G, Ramtoola Z

机构信息

Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Torino, Italy.

出版信息

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):463-72. doi: 10.1016/j.ejpb.2013.07.016. Epub 2013 Aug 1.

Abstract

Nanomedicine formulations such as biodegradable nanoparticles (nps) and liposomes offer several advantages over traditional routes of administration: due to their small size, nanocarriers are able to selectively accumulate inside tumours or inflammatory tissues, resulting in improved drug efficacy and reduced side effects. To further augment targeting ability of nanoparticles towards tumour cells, specific ligands or antibodies that selectively recognise biomarkers over-expressed on cancer cells, can be attached to the surface either by chemical bond or by hydrophilic/hydrophobic interactions. In the present work, Herceptin (HER), a monoclonal antibody (mAb) able to selectively recognise HER-2 over-expressing tumour cells (such as breast and ovarian cancer cells), was absorbed on the surface of nanoparticles through hydrophilic/hydrophobic interactions. Nps were prepared by a modified single emulsion solvent evaporation method with five different polymers: three commercial polyesters (poly(ε-caprolactone) (PCL), poly (D,L-lactide) (PLA) and poly (D,L-lactide-co-.glycolide) (PLGA)) and two novel biodegradable polyesterurethanes (PURs) based on Poly(ε-caprolactone) blocks, synthesised with different chain extenders (1,4-cyclohexane dimethanol (CDM) and N-Boc-serinol). Polyurethanes were introduced as matrix-forming materials for nanoparticles due to their high chemical versatility, which allows tailoring of the materials final properties by properly selecting the reagents. All nps exhibited a small size and negative surface charge, suitable for surface functionalisation with mAb through hydrophilic/hydrophobic interactions. The extent of cellular internalisation was tested on two different cell lines: MCF-7 and SK-BR-3 breast cancer cells showing a normal and a high expression of the HER-2 receptor, respectively. Paclitaxel, a model anti-neoplastic drug, was encapsulated inside all nps, and release profiles and cytotoxicity on SK-BR-3 cells were also assessed. Interestingly, PUR nps were superior to commercial polyester-based nps in terms of higher cellular internalisation and cytotoxic activity on the tested cell lines. Results obtained warrants further investigation on the application of these PUR nps for controlled drug delivery and targeting.

摘要

纳米医学制剂,如可生物降解的纳米颗粒(NPs)和脂质体,与传统给药途径相比具有多个优势:由于其尺寸小,纳米载体能够选择性地在肿瘤或炎症组织内积累,从而提高药物疗效并减少副作用。为了进一步增强纳米颗粒对肿瘤细胞的靶向能力,可以通过化学键或亲水/疏水相互作用将选择性识别癌细胞上过表达生物标志物的特异性配体或抗体附着在其表面。在本研究中,赫赛汀(HER),一种能够选择性识别过表达HER-2的肿瘤细胞(如乳腺癌和卵巢癌细胞)的单克隆抗体(mAb),通过亲水/疏水相互作用吸附在纳米颗粒表面。纳米颗粒采用改良的单乳液溶剂蒸发法,使用五种不同的聚合物制备:三种商业聚酯(聚(ε-己内酯)(PCL)、聚(D,L-丙交酯)(PLA)和聚(D,L-丙交酯-共-乙交酯)(PLGA))以及两种基于聚(ε-己内酯)嵌段、用不同扩链剂(1,4-环己烷二甲醇(CDM)和N-Boc-丝氨醇)合成的新型可生物降解聚酯聚氨酯(PURs)。聚氨酯因其高化学通用性而被用作纳米颗粒的基质形成材料,这使得通过适当选择试剂来定制材料的最终性能成为可能。所有纳米颗粒均呈现小尺寸和负表面电荷,适合通过亲水/疏水相互作用用单克隆抗体进行表面功能化。在两种不同的细胞系上测试了细胞内化程度:MCF-7和SK-BR-3乳腺癌细胞,分别显示HER-2受体的正常表达和高表达。紫杉醇,一种典型的抗肿瘤药物,被包裹在所有纳米颗粒内,并且还评估了其在SK-BR-3细胞上的释放曲线和细胞毒性。有趣的是,在测试细胞系上,聚氨酯纳米颗粒在更高的细胞内化和细胞毒性活性方面优于基于商业聚酯的纳米颗粒。所获得的结果值得对这些聚氨酯纳米颗粒在控释药物递送和靶向方面的应用进行进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验